Episode description

If you squint, it could be a trip back to 2017, when cannabis was on the cusp of becoming legal and most cities in Canada were inundated with 'dispensaries'—unlicensed retail storefronts selling pot as if it were already just fine. Mostly, crackdowns on those failed, pot became legal and everyone stopped caring. Until this year, when the cycle began again with a much different drug...

Now, stores with names like "Fun Guyz" and "Shroomyz" have opened across the country, and the enforcement, or lack thereof, seems similar to 2017. But how are these two situations—and two substances—different from the cannabis experience? What does the rise of retail 'shrooms' tell us about psychedelics in general? And is psilocybin really on track to become the next legal, recreational drug?

GUEST: Daniel Eisenkraft Klein, PhD Candidate at the Dalla Lana School of Public Health; Fellow at the Canadian Centre for Health Economics

We love feedback at The Big Story, as well as suggestions for future episodes. You can find us:

Through email at hello@thebigstorypodcast.ca 

Or @thebigstoryfpn on Twitter